nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0323	0.0546	CbGbCtD
Mefloquine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0322	0.0544	CbGbCtD
Mefloquine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0304	0.0513	CbGbCtD
Mefloquine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0304	0.0513	CbGbCtD
Mefloquine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0292	0.0492	CbGbCtD
Mefloquine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0275	0.0464	CbGbCtD
Mefloquine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0275	0.0464	CbGbCtD
Mefloquine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0252	0.0425	CbGbCtD
Mefloquine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0244	0.0413	CbGbCtD
Mefloquine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0237	0.04	CbGbCtD
Mefloquine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.023	0.0389	CbGbCtD
Mefloquine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0221	0.0373	CbGbCtD
Mefloquine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0221	0.0373	CbGbCtD
Mefloquine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0212	0.0358	CbGbCtD
Mefloquine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0208	0.0352	CbGbCtD
Mefloquine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0208	0.0352	CbGbCtD
Mefloquine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0205	0.0347	CbGbCtD
Mefloquine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0193	0.0326	CbGbCtD
Mefloquine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0193	0.0326	CbGbCtD
Mefloquine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0175	0.0295	CbGbCtD
Mefloquine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0175	0.0295	CbGbCtD
Mefloquine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0164	0.0277	CbGbCtD
Mefloquine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0151	0.0255	CbGbCtD
Mefloquine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0146	0.0247	CbGbCtD
Mefloquine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0132	0.0224	CbGbCtD
Mefloquine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0132	0.0224	CbGbCtD
Mefloquine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0127	0.0214	CbGbCtD
Mefloquine—HBA2—endothelium—acquired immunodeficiency syndrome	0.00654	0.0631	CbGeAlD
Mefloquine—HBA1—blood plasma—acquired immunodeficiency syndrome	0.00632	0.061	CbGeAlD
Mefloquine—HBA2—blood plasma—acquired immunodeficiency syndrome	0.00581	0.056	CbGeAlD
Mefloquine—HBA2—Scavenging of heme from plasma—ALB—acquired immunodeficiency syndrome	0.00499	0.0949	CbGpPWpGaD
Mefloquine—CYP19A1—semen—acquired immunodeficiency syndrome	0.00486	0.0469	CbGeAlD
Mefloquine—HBA1—Scavenging of heme from plasma—ALB—acquired immunodeficiency syndrome	0.00378	0.0719	CbGpPWpGaD
Mefloquine—ADORA1—nerve—acquired immunodeficiency syndrome	0.00345	0.0333	CbGeAlD
Mefloquine—HBA2—retina—acquired immunodeficiency syndrome	0.00318	0.0307	CbGeAlD
Mefloquine—HBA1—skin of body—acquired immunodeficiency syndrome	0.00304	0.0293	CbGeAlD
Mefloquine—HBA2—skin of body—acquired immunodeficiency syndrome	0.00279	0.0269	CbGeAlD
Mefloquine—HBA1—lymphoid tissue—acquired immunodeficiency syndrome	0.00246	0.0238	CbGeAlD
Mefloquine—HBA1—digestive system—acquired immunodeficiency syndrome	0.00243	0.0235	CbGeAlD
Mefloquine—HBA1—blood—acquired immunodeficiency syndrome	0.00232	0.0224	CbGeAlD
Mefloquine—HBA2—lymphoid tissue—acquired immunodeficiency syndrome	0.00226	0.0218	CbGeAlD
Mefloquine—HBA1—bone marrow—acquired immunodeficiency syndrome	0.00224	0.0216	CbGeAlD
Mefloquine—HBA2—digestive system—acquired immunodeficiency syndrome	0.00223	0.0215	CbGeAlD
Mefloquine—HBA1—spinal cord—acquired immunodeficiency syndrome	0.00223	0.0215	CbGeAlD
Mefloquine—HBA2—blood—acquired immunodeficiency syndrome	0.00213	0.0205	CbGeAlD
Mefloquine—HBA2—bone marrow—acquired immunodeficiency syndrome	0.00206	0.0199	CbGeAlD
Mefloquine—HBA2—spinal cord—acquired immunodeficiency syndrome	0.00205	0.0198	CbGeAlD
Mefloquine—HBA1—lung—acquired immunodeficiency syndrome	0.00203	0.0196	CbGeAlD
Mefloquine—HBA2—Binding and Uptake of Ligands by Scavenger Receptors—ALB—acquired immunodeficiency syndrome	0.00199	0.0379	CbGpPWpGaD
Mefloquine—HBA1—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.00197	0.0375	CbGpPWpGaD
Mefloquine—HBA1—nervous system—acquired immunodeficiency syndrome	0.00188	0.0181	CbGeAlD
Mefloquine—HBA2—lung—acquired immunodeficiency syndrome	0.00186	0.018	CbGeAlD
Mefloquine—HBA1—central nervous system—acquired immunodeficiency syndrome	0.00181	0.0175	CbGeAlD
Mefloquine—HBA2—nervous system—acquired immunodeficiency syndrome	0.00173	0.0167	CbGeAlD
Mefloquine—HBA2—central nervous system—acquired immunodeficiency syndrome	0.00166	0.016	CbGeAlD
Mefloquine—HBA1—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.00156	0.0296	CbGpPWpGaD
Mefloquine—HBA1—Binding and Uptake of Ligands by Scavenger Receptors—ALB—acquired immunodeficiency syndrome	0.00151	0.0287	CbGpPWpGaD
Mefloquine—HBA1—brain—acquired immunodeficiency syndrome	0.00144	0.0139	CbGeAlD
Mefloquine—ACHE—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.00144	0.0273	CbGpPWpGaD
Mefloquine—HBA1—lymph node—acquired immunodeficiency syndrome	0.00139	0.0134	CbGeAlD
Mefloquine—HBA2—brain—acquired immunodeficiency syndrome	0.00132	0.0127	CbGeAlD
Mefloquine—BCHE—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.00128	0.0244	CbGpPWpGaD
Mefloquine—HBA2—lymph node—acquired immunodeficiency syndrome	0.00128	0.0123	CbGeAlD
Mefloquine—BCHE—blood plasma—acquired immunodeficiency syndrome	0.00127	0.0123	CbGeAlD
Mefloquine—HBA1—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.00127	0.0241	CbGpPWpGaD
Mefloquine—ADORA2A—lymphoid tissue—acquired immunodeficiency syndrome	0.00118	0.0114	CbGeAlD
Mefloquine—ADORA1—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.00117	0.0223	CbGpPWpGaD
Mefloquine—HBA1—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.00116	0.022	CbGpPWpGaD
Mefloquine—ADORA2A—blood—acquired immunodeficiency syndrome	0.00111	0.0107	CbGeAlD
Mefloquine—ADORA2A—spinal cord—acquired immunodeficiency syndrome	0.00107	0.0103	CbGeAlD
Mefloquine—HBA1—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.00103	0.0196	CbGpPWpGaD
Mefloquine—HBA1—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.00094	0.0179	CbGpPWpGaD
Mefloquine—ADORA1—spinal cord—acquired immunodeficiency syndrome	0.000921	0.00889	CbGeAlD
Mefloquine—ACHE—spinal cord—acquired immunodeficiency syndrome	0.000915	0.00883	CbGeAlD
Mefloquine—ADORA2A—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000903	0.0172	CbGpPWpGaD
Mefloquine—ADORA2A—nervous system—acquired immunodeficiency syndrome	0.000899	0.00867	CbGeAlD
Mefloquine—ADORA1—vagina—acquired immunodeficiency syndrome	0.000886	0.00855	CbGeAlD
Mefloquine—ADORA2A—central nervous system—acquired immunodeficiency syndrome	0.000865	0.00835	CbGeAlD
Mefloquine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000858	0.00828	CbGeAlD
Mefloquine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000844	0.00815	CbGeAlD
Mefloquine—ADORA1—lung—acquired immunodeficiency syndrome	0.000838	0.00809	CbGeAlD
Mefloquine—HBA1—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000836	0.0159	CbGpPWpGaD
Mefloquine—HBA1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000819	0.0156	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.000782	0.0149	CbGpPWpGaD
Mefloquine—ADORA1—nervous system—acquired immunodeficiency syndrome	0.000776	0.00749	CbGeAlD
Mefloquine—HBA1—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000748	0.0142	CbGpPWpGaD
Mefloquine—ADORA1—central nervous system—acquired immunodeficiency syndrome	0.000747	0.00721	CbGeAlD
Mefloquine—HBA1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000747	0.0142	CbGpPWpGaD
Mefloquine—ADORA2A—brain—acquired immunodeficiency syndrome	0.000687	0.00663	CbGeAlD
Mefloquine—CYP19A1—blood—acquired immunodeficiency syndrome	0.000648	0.00625	CbGeAlD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000622	0.0118	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—TAT—acquired immunodeficiency syndrome	0.00062	0.0118	CbGpPWpGaD
Mefloquine—BCHE—skin of body—acquired immunodeficiency syndrome	0.000613	0.00591	CbGeAlD
Mefloquine—HBA1—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000609	0.0116	CbGpPWpGaD
Mefloquine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000607	0.00586	CbGeAlD
Mefloquine—HBA1—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000604	0.0115	CbGpPWpGaD
Mefloquine—ADORA1—brain—acquired immunodeficiency syndrome	0.000593	0.00572	CbGeAlD
Mefloquine—ACHE—brain—acquired immunodeficiency syndrome	0.000589	0.00569	CbGeAlD
Mefloquine—ADORA1—lymph node—acquired immunodeficiency syndrome	0.000573	0.00553	CbGeAlD
Mefloquine—ACHE—lymph node—acquired immunodeficiency syndrome	0.00057	0.0055	CbGeAlD
Mefloquine—HBA2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000527	0.01	CbGpPWpGaD
Mefloquine—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.000526	0.00508	CbGeAlD
Mefloquine—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.000507	0.00489	CbGeAlD
Mefloquine—HBA1—Folate Metabolism—IL6—acquired immunodeficiency syndrome	0.000491	0.00935	CbGpPWpGaD
Mefloquine—BCHE—digestive system—acquired immunodeficiency syndrome	0.00049	0.00473	CbGeAlD
Mefloquine—HBA1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	0.000483	0.0092	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.00048	0.00914	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000474	0.00901	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—TAT—acquired immunodeficiency syndrome	0.00047	0.00894	CbGpPWpGaD
Mefloquine—BCHE—blood—acquired immunodeficiency syndrome	0.000467	0.00451	CbGeAlD
Mefloquine—BCHE—bone marrow—acquired immunodeficiency syndrome	0.000452	0.00436	CbGeAlD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—APOBEC3G—acquired immunodeficiency syndrome	0.00045	0.00856	CbGpPWpGaD
Mefloquine—BCHE—spinal cord—acquired immunodeficiency syndrome	0.00045	0.00434	CbGeAlD
Mefloquine—BCHE—vagina—acquired immunodeficiency syndrome	0.000433	0.00418	CbGeAlD
Mefloquine—BCHE—lung—acquired immunodeficiency syndrome	0.000409	0.00395	CbGeAlD
Mefloquine—CYP19A1—brain—acquired immunodeficiency syndrome	0.000402	0.00388	CbGeAlD
Mefloquine—HBA1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000399	0.0076	CbGpPWpGaD
Mefloquine—HBA1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	0.00039	0.00743	CbGpPWpGaD
Mefloquine—CYP19A1—lymph node—acquired immunodeficiency syndrome	0.000389	0.00375	CbGeAlD
Mefloquine—BCHE—nervous system—acquired immunodeficiency syndrome	0.000379	0.00366	CbGeAlD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000377	0.00717	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000366	0.00696	CbGpPWpGaD
Mefloquine—BCHE—central nervous system—acquired immunodeficiency syndrome	0.000365	0.00352	CbGeAlD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000341	0.00649	CbGpPWpGaD
Mefloquine—ABCB1—retina—acquired immunodeficiency syndrome	0.000333	0.00321	CbGeAlD
Mefloquine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00033	0.00318	CbGeAlD
Mefloquine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000325	0.00313	CbGeAlD
Mefloquine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000314	0.00303	CbGeAlD
Mefloquine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000309	0.00298	CbGeAlD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000291	0.00554	CbGpPWpGaD
Mefloquine—BCHE—brain—acquired immunodeficiency syndrome	0.00029	0.0028	CbGeAlD
Mefloquine—ADORA1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000287	0.00546	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000281	0.00536	CbGpPWpGaD
Mefloquine—BCHE—lymph node—acquired immunodeficiency syndrome	0.00028	0.0027	CbGeAlD
Mefloquine—ADORA2A—Monoamine Transport—TNF—acquired immunodeficiency syndrome	0.000273	0.0052	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000271	0.00516	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000265	0.00504	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000263	0.00501	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000259	0.00494	CbGpPWpGaD
Mefloquine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000255	0.00246	CbGeAlD
Mefloquine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000251	0.00242	CbGeAlD
Mefloquine—ADORA1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000249	0.00474	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000249	0.00474	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000246	0.00468	CbGpPWpGaD
Mefloquine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000246	0.00237	CbGeAlD
Mefloquine—ADORA1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000243	0.00463	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000242	0.0046	CbGpPWpGaD
Mefloquine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000242	0.00233	CbGeAlD
Mefloquine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000236	0.00228	CbGeAlD
Mefloquine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000234	0.00225	CbGeAlD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000233	0.00443	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000231	0.0044	CbGpPWpGaD
Mefloquine—ABCB1—blood—acquired immunodeficiency syndrome	0.000223	0.00215	CbGeAlD
Mefloquine—ADORA2A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000222	0.00422	CbGpPWpGaD
Mefloquine—ACHE—Monoamine Transport—TNF—acquired immunodeficiency syndrome	0.000218	0.00415	CbGpPWpGaD
Mefloquine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000215	0.00208	CbGeAlD
Mefloquine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000214	0.00207	CbGeAlD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000211	0.00401	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000207	0.00393	CbGpPWpGaD
Mefloquine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000206	0.00199	CbGeAlD
Mefloquine—ADORA2A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0002	0.00381	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000198	0.00377	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000198	0.00377	CbGpPWpGaD
Mefloquine—ABCB1—lung—acquired immunodeficiency syndrome	0.000195	0.00188	CbGeAlD
Mefloquine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000192	0.00185	CbGeAlD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.00019	0.00361	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000189	0.0036	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000188	0.00357	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000185	0.00351	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000185	0.00351	CbGpPWpGaD
Mefloquine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000181	0.00174	CbGeAlD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.00018	0.00343	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00018	0.00342	CbGpPWpGaD
Mefloquine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000713	CcSEcCtD
Mefloquine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000179	0.000712	CcSEcCtD
Mefloquine—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000712	CcSEcCtD
Mefloquine—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000711	CcSEcCtD
Mefloquine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.00071	CcSEcCtD
Mefloquine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.00071	CcSEcCtD
Mefloquine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000709	CcSEcCtD
Mefloquine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.000709	CcSEcCtD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000178	0.00339	CbGpPWpGaD
Mefloquine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000708	CcSEcCtD
Mefloquine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000178	0.000707	CcSEcCtD
Mefloquine—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000178	0.000706	CcSEcCtD
Mefloquine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.000705	CcSEcCtD
Mefloquine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000178	0.000705	CcSEcCtD
Mefloquine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000177	0.000704	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000177	0.00337	CbGpPWpGaD
Mefloquine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000177	0.000703	CcSEcCtD
Mefloquine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000177	0.000702	CcSEcCtD
Mefloquine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.000702	CcSEcCtD
Mefloquine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000701	CcSEcCtD
Mefloquine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000701	CcSEcCtD
Mefloquine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000701	CcSEcCtD
Mefloquine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000701	CcSEcCtD
Mefloquine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000698	CcSEcCtD
Mefloquine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000698	CcSEcCtD
Mefloquine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000696	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.000696	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000175	0.000694	CcSEcCtD
Mefloquine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000174	0.000693	CcSEcCtD
Mefloquine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000174	0.000693	CcSEcCtD
Mefloquine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000692	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.000692	CcSEcCtD
Mefloquine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000174	0.00168	CbGeAlD
Mefloquine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.000687	CcSEcCtD
Mefloquine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000173	0.000686	CcSEcCtD
Mefloquine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000686	CcSEcCtD
Mefloquine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000684	CcSEcCtD
Mefloquine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.000683	CcSEcCtD
Mefloquine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.000683	CcSEcCtD
Mefloquine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000172	0.000682	CcSEcCtD
Mefloquine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.000682	CcSEcCtD
Mefloquine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000681	CcSEcCtD
Mefloquine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000171	0.00068	CcSEcCtD
Mefloquine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000171	0.00068	CcSEcCtD
Mefloquine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000679	CcSEcCtD
Mefloquine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000679	CcSEcCtD
Mefloquine—ADORA1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000171	0.00325	CbGpPWpGaD
Mefloquine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000678	CcSEcCtD
Mefloquine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000677	CcSEcCtD
Mefloquine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.000677	CcSEcCtD
Mefloquine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000676	CcSEcCtD
Mefloquine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.000675	CcSEcCtD
Mefloquine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000674	CcSEcCtD
Mefloquine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000674	CcSEcCtD
Mefloquine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000674	CcSEcCtD
Mefloquine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000672	CcSEcCtD
Mefloquine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000672	CcSEcCtD
Mefloquine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000169	0.00067	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.00067	CcSEcCtD
Mefloquine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000668	CcSEcCtD
Mefloquine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000666	CcSEcCtD
Mefloquine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000664	CcSEcCtD
Mefloquine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000167	0.000662	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000662	CcSEcCtD
Mefloquine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000661	CcSEcCtD
Mefloquine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.00066	CcSEcCtD
Mefloquine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000166	0.000659	CcSEcCtD
Mefloquine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000659	CcSEcCtD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000166	0.00315	CbGpPWpGaD
Mefloquine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000658	CcSEcCtD
Mefloquine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000165	0.000657	CcSEcCtD
Mefloquine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000165	0.000657	CcSEcCtD
Mefloquine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.000657	CcSEcCtD
Mefloquine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000655	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000655	CcSEcCtD
Mefloquine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000655	CcSEcCtD
Mefloquine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000165	0.000654	CcSEcCtD
Mefloquine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000654	CcSEcCtD
Mefloquine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000652	CcSEcCtD
Mefloquine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.000652	CcSEcCtD
Mefloquine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000652	CcSEcCtD
Mefloquine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000649	CcSEcCtD
Mefloquine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000163	0.000649	CcSEcCtD
Mefloquine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000163	0.000648	CcSEcCtD
Mefloquine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000647	CcSEcCtD
Mefloquine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000163	0.000647	CcSEcCtD
Mefloquine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000646	CcSEcCtD
Mefloquine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000646	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000163	0.00309	CbGpPWpGaD
Mefloquine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000162	0.000645	CcSEcCtD
Mefloquine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000643	CcSEcCtD
Mefloquine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000643	CcSEcCtD
Mefloquine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000643	CcSEcCtD
Mefloquine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000641	CcSEcCtD
Mefloquine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000639	CcSEcCtD
Mefloquine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000639	CcSEcCtD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000161	0.00306	CbGpPWpGaD
Mefloquine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000161	0.000638	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00016	0.00305	CbGpPWpGaD
Mefloquine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000636	CcSEcCtD
Mefloquine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000636	CcSEcCtD
Mefloquine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000635	CcSEcCtD
Mefloquine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000635	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	0.00016	0.00304	CbGpPWpGaD
Mefloquine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000634	CcSEcCtD
Mefloquine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00016	0.000634	CcSEcCtD
Mefloquine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000633	CcSEcCtD
Mefloquine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000159	0.000632	CcSEcCtD
Mefloquine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000631	CcSEcCtD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000158	0.00301	CbGpPWpGaD
Mefloquine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000158	0.000629	CcSEcCtD
Mefloquine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000158	0.000628	CcSEcCtD
Mefloquine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000628	CcSEcCtD
Mefloquine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000628	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000627	CcSEcCtD
Mefloquine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000158	0.000627	CcSEcCtD
Mefloquine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000626	CcSEcCtD
Mefloquine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000158	0.000626	CcSEcCtD
Mefloquine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000157	0.000625	CcSEcCtD
Mefloquine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000625	CcSEcCtD
Mefloquine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000157	0.000625	CcSEcCtD
Mefloquine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000157	0.000623	CcSEcCtD
Mefloquine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000157	0.000623	CcSEcCtD
Mefloquine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000622	CcSEcCtD
Mefloquine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000621	CcSEcCtD
Mefloquine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000156	0.00062	CcSEcCtD
Mefloquine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000155	0.000617	CcSEcCtD
Mefloquine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000155	0.000617	CcSEcCtD
Mefloquine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000617	CcSEcCtD
Mefloquine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000617	CcSEcCtD
Mefloquine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000154	0.000613	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000612	CcSEcCtD
Mefloquine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000154	0.000611	CcSEcCtD
Mefloquine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.000611	CcSEcCtD
Mefloquine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000607	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000153	0.00291	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000153	0.00291	CbGpPWpGaD
Mefloquine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000607	CcSEcCtD
Mefloquine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000605	CcSEcCtD
Mefloquine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000604	CcSEcCtD
Mefloquine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000604	CcSEcCtD
Mefloquine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000603	CcSEcCtD
Mefloquine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000152	0.000603	CcSEcCtD
Mefloquine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.0006	CcSEcCtD
Mefloquine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.0006	CcSEcCtD
Mefloquine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000599	CcSEcCtD
Mefloquine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000599	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000151	0.00287	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000151	0.00287	CbGpPWpGaD
Mefloquine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000598	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000151	0.00287	CbGpPWpGaD
Mefloquine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000597	CcSEcCtD
Mefloquine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000596	CcSEcCtD
Mefloquine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00015	0.000594	CcSEcCtD
Mefloquine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000149	0.000592	CcSEcCtD
Mefloquine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000592	CcSEcCtD
Mefloquine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000591	CcSEcCtD
Mefloquine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.000591	CcSEcCtD
Mefloquine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000149	0.00059	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000589	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000147	0.0028	CbGpPWpGaD
Mefloquine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000585	CcSEcCtD
Mefloquine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000584	CcSEcCtD
Mefloquine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000146	0.000582	CcSEcCtD
Mefloquine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.00058	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.00058	CcSEcCtD
Mefloquine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000579	CcSEcCtD
Mefloquine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000577	CcSEcCtD
Mefloquine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000576	CcSEcCtD
Mefloquine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000576	CcSEcCtD
Mefloquine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000576	CcSEcCtD
Mefloquine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000575	CcSEcCtD
Mefloquine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000574	CcSEcCtD
Mefloquine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000574	CcSEcCtD
Mefloquine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000144	0.000571	CcSEcCtD
Mefloquine—ADORA1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000144	0.00273	CbGpPWpGaD
Mefloquine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000569	CcSEcCtD
Mefloquine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000568	CcSEcCtD
Mefloquine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000141	0.000562	CcSEcCtD
Mefloquine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000562	CcSEcCtD
Mefloquine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000559	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000558	CcSEcCtD
Mefloquine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000558	CcSEcCtD
Mefloquine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000557	CcSEcCtD
Mefloquine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000554	CcSEcCtD
Mefloquine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000553	CcSEcCtD
Mefloquine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00055	CcSEcCtD
Mefloquine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000138	0.00055	CcSEcCtD
Mefloquine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000549	CcSEcCtD
Mefloquine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000549	CcSEcCtD
Mefloquine—ABCB1—brain—acquired immunodeficiency syndrome	0.000138	0.00133	CbGeAlD
Mefloquine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000548	CcSEcCtD
Mefloquine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.000545	CcSEcCtD
Mefloquine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000545	CcSEcCtD
Mefloquine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000137	0.000544	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000137	0.0026	CbGpPWpGaD
Mefloquine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000543	CcSEcCtD
Mefloquine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000136	0.000541	CcSEcCtD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000136	0.00258	CbGpPWpGaD
Mefloquine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000537	CcSEcCtD
Mefloquine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000536	CcSEcCtD
Mefloquine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000535	CcSEcCtD
Mefloquine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000534	CcSEcCtD
Mefloquine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000533	CcSEcCtD
Mefloquine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000532	CcSEcCtD
Mefloquine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000532	CcSEcCtD
Mefloquine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000134	0.000531	CcSEcCtD
Mefloquine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000531	CcSEcCtD
Mefloquine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000531	CcSEcCtD
Mefloquine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000133	0.00129	CbGeAlD
Mefloquine—ADORA1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000133	0.00253	CbGpPWpGaD
Mefloquine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000529	CcSEcCtD
Mefloquine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000521	CcSEcCtD
Mefloquine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.000519	CcSEcCtD
Mefloquine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000514	CcSEcCtD
Mefloquine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000514	CcSEcCtD
Mefloquine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000129	0.000513	CcSEcCtD
Mefloquine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000511	CcSEcCtD
Mefloquine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000511	CcSEcCtD
Mefloquine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000511	CcSEcCtD
Mefloquine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000508	CcSEcCtD
Mefloquine—Rash—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000507	CcSEcCtD
Mefloquine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000506	CcSEcCtD
Mefloquine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000504	CcSEcCtD
Mefloquine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000127	0.000503	CcSEcCtD
Mefloquine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.000502	CcSEcCtD
Mefloquine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000497	CcSEcCtD
Mefloquine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000495	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000124	0.00236	CbGpPWpGaD
Mefloquine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.00049	CcSEcCtD
Mefloquine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000487	CcSEcCtD
Mefloquine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000487	CcSEcCtD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000122	0.00233	CbGpPWpGaD
Mefloquine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000483	CcSEcCtD
Mefloquine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000482	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	0.000121	0.00231	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	0.000121	0.00231	CbGpPWpGaD
Mefloquine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.00048	CcSEcCtD
Mefloquine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000479	CcSEcCtD
Mefloquine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000478	CcSEcCtD
Mefloquine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000477	CcSEcCtD
Mefloquine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000476	CcSEcCtD
Mefloquine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00012	0.000476	CcSEcCtD
Mefloquine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000475	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	0.000118	0.00224	CbGpPWpGaD
Mefloquine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000464	CcSEcCtD
Mefloquine—ADORA2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000116	0.00221	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000116	0.00221	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000116	0.00221	CbGpPWpGaD
Mefloquine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000462	CcSEcCtD
Mefloquine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.00046	CcSEcCtD
Mefloquine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000458	CcSEcCtD
Mefloquine—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	0.000115	0.00219	CbGpPWpGaD
Mefloquine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000457	CcSEcCtD
Mefloquine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000457	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000115	0.00218	CbGpPWpGaD
Mefloquine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000115	0.000455	CcSEcCtD
Mefloquine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000454	CcSEcCtD
Mefloquine—ADORA2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000114	0.00216	CbGpPWpGaD
Mefloquine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000114	0.000451	CcSEcCtD
Mefloquine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000444	CcSEcCtD
Mefloquine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000442	CcSEcCtD
Mefloquine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000442	CcSEcCtD
Mefloquine—ADORA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000111	0.00211	CbGpPWpGaD
Mefloquine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000436	CcSEcCtD
Mefloquine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000431	CcSEcCtD
Mefloquine—HBA2—Metabolism—ALB—acquired immunodeficiency syndrome	0.000108	0.00206	CbGpPWpGaD
Mefloquine—ACHE—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000108	0.00205	CbGpPWpGaD
Mefloquine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000427	CcSEcCtD
Mefloquine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000427	CcSEcCtD
Mefloquine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000423	CcSEcCtD
Mefloquine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000423	CcSEcCtD
Mefloquine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000422	CcSEcCtD
Mefloquine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000106	0.000421	CcSEcCtD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000105	0.00199	CbGpPWpGaD
Mefloquine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000411	CcSEcCtD
Mefloquine—ADORA1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000103	0.00197	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000103	0.00196	CbGpPWpGaD
Mefloquine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000408	CcSEcCtD
Mefloquine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000408	CcSEcCtD
Mefloquine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000407	CcSEcCtD
Mefloquine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000102	0.000405	CcSEcCtD
Mefloquine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000399	CcSEcCtD
Mefloquine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	9.87e-05	0.000392	CcSEcCtD
Mefloquine—Rash—Lamivudine—acquired immunodeficiency syndrome	9.79e-05	0.000389	CcSEcCtD
Mefloquine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.78e-05	0.000388	CcSEcCtD
Mefloquine—Headache—Lamivudine—acquired immunodeficiency syndrome	9.73e-05	0.000386	CcSEcCtD
Mefloquine—Nausea—Saquinavir—acquired immunodeficiency syndrome	9.67e-05	0.000384	CcSEcCtD
Mefloquine—ACHE—Metabolism—TAT—acquired immunodeficiency syndrome	9.44e-05	0.0018	CbGpPWpGaD
Mefloquine—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.22e-05	0.000366	CcSEcCtD
Mefloquine—ADORA1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	9.1e-05	0.00173	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	9.06e-05	0.00172	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	8.85e-05	0.00168	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	8.7e-05	0.00166	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	8.7e-05	0.00166	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—TAT—acquired immunodeficiency syndrome	8.67e-05	0.00165	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	8.52e-05	0.00162	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	8.52e-05	0.00162	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—TAT—acquired immunodeficiency syndrome	8.42e-05	0.0016	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	8.23e-05	0.00157	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—ALB—acquired immunodeficiency syndrome	8.19e-05	0.00156	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—AGPS—acquired immunodeficiency syndrome	8.02e-05	0.00153	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	7.98e-05	0.00152	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	7.87e-05	0.0015	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	7.73e-05	0.00147	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	7.73e-05	0.00147	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.37e-05	0.0014	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—AGPS—acquired immunodeficiency syndrome	7.16e-05	0.00136	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	7.12e-05	0.00136	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	7.02e-05	0.00134	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.99e-05	0.00133	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.72e-05	0.00128	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.72e-05	0.00128	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	6.58e-05	0.00125	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	6.58e-05	0.00125	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	6.57e-05	0.00125	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	6.48e-05	0.00123	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	6.38e-05	0.00121	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	6.35e-05	0.00121	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	6.33e-05	0.0012	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	6.07e-05	0.00116	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.97e-05	0.00114	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.97e-05	0.00114	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	5.88e-05	0.00112	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	5.84e-05	0.00111	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	5.8e-05	0.0011	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	5.37e-05	0.00102	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	5.3e-05	0.00101	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	5.23e-05	0.000995	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	5.07e-05	0.000965	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	5e-05	0.000952	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	4.97e-05	0.000946	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.93e-05	0.000938	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	4.86e-05	0.000925	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	4.61e-05	0.000877	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	4.57e-05	0.00087	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	4.57e-05	0.00087	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.54e-05	0.000865	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.51e-05	0.000858	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.48e-05	0.000852	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	4.15e-05	0.00079	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	4.11e-05	0.000782	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	4.09e-05	0.000779	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	3.87e-05	0.000737	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—IL6—acquired immunodeficiency syndrome	3.82e-05	0.000728	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.75e-05	0.000714	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.7e-05	0.000703	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.53e-05	0.000671	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.53e-05	0.000671	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.49e-05	0.000665	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.48e-05	0.000662	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.42e-05	0.000652	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.4e-05	0.000646	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.37e-05	0.000642	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.3e-05	0.000627	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	3.29e-05	0.000626	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.13e-05	0.000596	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.06e-05	0.000583	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.68e-05	0.000511	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.64e-05	0.000503	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.6e-05	0.000496	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.53e-05	0.000482	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.42e-05	0.00046	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.36e-05	0.00045	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.27e-05	0.000433	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.15e-05	0.00041	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.81e-05	0.000344	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.8e-05	0.000343	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—ALB—acquired immunodeficiency syndrome	1.65e-05	0.000313	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.53e-05	0.000291	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—ALB—acquired immunodeficiency syndrome	1.51e-05	0.000288	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—ALB—acquired immunodeficiency syndrome	1.47e-05	0.000279	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.4e-05	0.000266	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.39e-05	0.000265	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.06e-05	0.000202	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.21e-06	0.000156	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	7.16e-06	0.000136	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	6.75e-06	0.000128	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.41e-06	8.4e-05	CbGpPWpGaD
